Cervical cancer burden and prevention strategies: Asia Oceania perspective.

Asia Oceania Guidelines for the Implementation of Programs for Cervical Cancer Prevention and Control

This paper aims to provide evidence-based recommendations for health professionals, to develop a comprehensive cervical cancer program for a clinic, a community, or a country. Ensuring access to healthcare is the responsibility of all societies, and the Asia Oceania Research Organisation in Genital Infections and Neoplasia (AOGIN) is committed to working collaboratively with governments and hea...

Combat against cervical cancer-challenges in Asia Oceania: 5th Biennial Conference of the Asia Oceania Research Organization on Genital Infections & Neoplasia (AOGIN)

Comprehensive cervical cancer prevention and control in the Asia Pacific region: the 6th Biennial Conference of the Asia Oceania Research Organization on Genital Infections & Neoplasia (AOGIN)

As the leading cancer killer of women in developing countries, cervical cancer accounts for more than a quarter million deaths each year, more than 50% of cases occur within the Asian-Pacific region, which can be prevented by appropriate interventions. Therefore, in 2005, we have developed an expert multi-disciplinary group within the region and along the lines of European Research Organization...

Assessment of the Broader Economic Consequences of HPV Prevention from a Government-Perspective: A Fiscal Analytic Approach

BACKGROUND Cervical cancer poses a substantial burden in terms of morbidity, mortality, and economic losses, especially in low/middle-income countries. HPV vaccination and/or cervical cancer screening among females may reduce the burden of HPV-related diseases, including cervical cancer. However, limited funds may impede the implementation of population-based programmes. Governmental investment...

Meta-Analysis on Prevalence and Attribution of Human Papillomavirus Types 52 and 58 in Cervical Neoplasia Worldwide

OBJECTIVE To estimate the prevalence and attribution of two non-vaccine-covered HPV types (HPV52 and HPV58) across the world. METHODS Meta-analysis on studies reported in English and Chinese between 1994 and 2012. RESULTS The pooled prevalence and attribution rates of HPV52 and HPV58 in invasive cervical cancers were significantly higher in Eastern Asia compared to other regions (HPV52 prev...